ARS Pharmaceuticals (SPRY) Q2 2025 Earnings

14MayConfirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-0.35
-0.07
0.2
0.48

Details

Expected EPS
-0.338333
Actual EPS
-0.35
Surprise EPS
-0.01
Surprise Percent
+3.45%

Description

ARS Pharmaceuticals (SPRY) has reported earnings of -0.35 per share for Q2 2025.

0 Comments

Share your thoughts